ROBINS HARLAN S (Chief Scientific Officer) sold 0.7% of their position (10K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $148.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/10/2026ACC: 0001780851-26-000011
Officer· Chief Scientific Officer
Since Jun 2019
-10K
Net shares
Net seller
$148.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10K
Price / share
$14.85
Trade value
$148.50K
% of position
0.7%
4/8/2026
1.52M→1.51M
Total
Net shares
−10K
Net value
-$148.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/8/2026 | S · Sale | −10K | $14.85 | $148.50K | 0.7% | 1.52M | 1.51M |
| Total | −10K | -$148.50K | ||||||
Derivative Transactions0
No derivative transactions reported